CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms

被引:1537
作者
Parry, RV
Chemnitz, JM
Frauwirth, KA
Lanfranco, AR
Braunstein, I
Kobayashi, SV
Linsley, PS
Thompson, CB
Riley, JL
机构
[1] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA
[4] Rosetta Inpharmat, Kirkland, WA 98034 USA
关键词
D O I
10.1128/MCB.25.21.9543-9553.2005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CTLA-4 and PD-1 are receptors that negatively regulate T-cell activation. Ligation of both CTLA-4 and PD-1 blocked CD3/CD28-mediated upregulation of glucose metabolism and Akt activity, but each accomplished this regulation using separate mechanisms. CTLA-4-mediated inhibition of Akt phosphorylation is sensitive to okadaic acid, providing direct evidence that PP2A plays a prominent role in mediating CTLA-4 suppression of T-cell activation. In contrast, PD-1 signaling inhibits Akt phosphorylation by preventing CD28-mediated activation of phosphatidylinositol 3-kinase (PI3K). The ability of PD-1 to suppress PI3K/AKT activation was dependent upon the immunoreceptor tyrosine-based switch motif located in its cytoplasmic tail, adding further importance to this domain in mediating PD-1 signal transduction. Lastly, PD-1 ligation is more effective in suppressing CD3/CD28-induced changes in the T-cell transcriptional profile, suggesting that differential regulation of PI3K activation by PD-1 and CTLA-4 ligation results in distinct cellular phenotypes. Together, these data suggest that CTLA-4 and PD-1 inhibit T-cell activation through distinct and potentially synergistic mechanisms.
引用
收藏
页码:9543 / 9553
页数:11
相关论文
共 73 条
[1]   Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes [J].
Agata, Y ;
Kawasaki, A ;
Nishimura, H ;
Ishida, Y ;
Tsubata, T ;
Yagita, H ;
Honjo, T .
INTERNATIONAL IMMUNOLOGY, 1996, 8 (05) :765-772
[2]   CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells [J].
Appleman, LJ ;
van Puijenbroek, AAFL ;
Shu, KM ;
Nadler, LM ;
Boussiotis, VA .
JOURNAL OF IMMUNOLOGY, 2002, 168 (06) :2729-2736
[3]   Inhibition of CTLA-4 function by the regulatory subunit of serine/threonine phosphatase 2A [J].
Baroja, ML ;
Vijayakrishnan, L ;
Bettelli, E ;
Darlington, PJ ;
Chau, TA ;
Ling, V ;
Collins, M ;
Carreno, BM ;
Madrenas, J ;
Kuchroo, VK .
JOURNAL OF IMMUNOLOGY, 2002, 168 (10) :5070-5078
[4]   Regulation of GLUT1 gene transcription by the serine threonine kinase Akt1 [J].
Barthel, A ;
Okino, ST ;
Liao, JF ;
Nakatani, K ;
Li, JP ;
Whitlock, JP ;
Roth, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20281-20286
[5]   Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: Attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses [J].
Bennett, F ;
Luxenberg, D ;
Ling, V ;
Wang, IM ;
Marquette, K ;
Lowe, D ;
Khan, N ;
Veldman, G ;
Jacobs, KA ;
Valge-Archer, VE ;
Collins, M ;
Carreno, BM .
JOURNAL OF IMMUNOLOGY, 2003, 170 (02) :711-718
[6]   INHIBITORY EFFECT OF A MARINE-SPONGE TOXIN, OKADAIC ACID, ON PROTEIN PHOSPHATASES - SPECIFICITY AND KINETICS [J].
BIALOJAN, C ;
TAKAI, A .
BIOCHEMICAL JOURNAL, 1988, 256 (01) :283-290
[7]  
Blair PJ, 1998, J IMMUNOL, V160, P12
[8]   CD28 COSTIMULATION CAN PROMOTE T-CELL SURVIVAL BY ENHANCING THE EXPRESSION OF BCL-X(L) [J].
BOISE, LH ;
MINN, AJ ;
NOEL, PJ ;
JUNE, CH ;
ACCAVITTI, MA ;
LINDSTEN, T ;
THOMPSON, CB .
IMMUNITY, 1995, 3 (01) :87-98
[9]   CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression [J].
Carreno, BM ;
Bennett, F ;
Chau, TA ;
Ling, V ;
Luxenberg, D ;
Jussif, J ;
Baroja, ML ;
Madrenas, J .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1352-1356
[10]   The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses [J].
Carreno, BM ;
Collins, M .
ANNUAL REVIEW OF IMMUNOLOGY, 2002, 20 :29-53